Literature DB >> 16414972

Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis.

M Otero1, R Lago, R Gomez, F Lago, C Dieguez, J J Gómez-Reino, O Gualillo.   

Abstract

BACKGROUND: Rheumatoid arthritis is a chronic autoimmune inflammatory condition characterised by polyarthritis and severe change in body mass and neuroendocrine environment.
OBJECTIVES: To investigate plasma levels of adipocytokines (leptin, adiponectin, visfatin and resistin) in patients with rheumatoid arthritis and to compare them with levels in healthy controls.
METHODS: Adiponectin, resistin, visfatin and leptin concentrations were measured in 31 patients with rheumatoid arthritis and 18 healthy controls by using specific enzyme-linked immunosorbent assays.
RESULTS: Patients with rheumatoid arthritis showed considerably higher plasma levels of leptin, adiponectin and visfatin than healthy controls. No marked difference was observed in resistin levels between patients and controls.
CONCLUSION: A marked increase in plasma levels of leptin, adiponectin and visfatin was noted in patients with rheumatoid arthritis, whereas resistin levels were similar to those observed in healthy controls. Coordinated roles for adiponectin, leptin and visfatin are suggested in the modulation of the inflammatory environment in patients with rheumatoid arthritis, whereas the lack of modulation in resistin levels is predictive of an irrelevant role for this peptide, suggesting that resistin level is probably not one of the main signals associated with the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16414972      PMCID: PMC1798289          DOI: 10.1136/ard.2005.046540

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Adipocytokines in synovial fluid.

Authors:  Andreas Schäffler; Angela Ehling; Elena Neumann; Hans Herfarth; Ingo Tarner; Jürgen Schölmerich; Ulf Müller-Ladner; Steffen Gay
Journal:  JAMA       Date:  2003-10-01       Impact factor: 56.272

Review 2.  Signalling role of adipose tissue: adipokines and inflammation in obesity.

Authors:  P Trayhurn; I S Wood
Journal:  Biochem Soc Trans       Date:  2005-11       Impact factor: 5.407

3.  Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.

Authors:  Atsunori Fukuhara; Morihiro Matsuda; Masako Nishizawa; Katsumori Segawa; Masaki Tanaka; Kae Kishimoto; Yasushi Matsuki; Mirei Murakami; Tomoko Ichisaka; Hiroko Murakami; Eijiro Watanabe; Toshiyuki Takagi; Megumi Akiyoshi; Tsuguteru Ohtsubo; Shinji Kihara; Shizuya Yamashita; Makoto Makishima; Tohru Funahashi; Shinya Yamanaka; Ryuji Hiramatsu; Yuji Matsuzawa; Iichiro Shimomura
Journal:  Science       Date:  2004-12-16       Impact factor: 47.728

4.  Elevated serum leptin concentrations induced by experimental acute inflammation.

Authors:  O Gualillo; S Eiras; F Lago; C Diéguez; F F Casanueva
Journal:  Life Sci       Date:  2000-10-06       Impact factor: 5.037

Review 5.  Leptin, from fat to inflammation: old questions and new insights.

Authors:  Miguel Otero; Rocío Lago; Francisca Lago; Felipe F Casanueva; Carlos Dieguez; Juan Jesús Gómez-Reino; Oreste Gualillo
Journal:  FEBS Lett       Date:  2005-01-17       Impact factor: 4.124

6.  Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells.

Authors:  Miguel Otero; Juan Jesús Gomez Reino; Oreste Gualillo
Journal:  Arthritis Rheum       Date:  2003-02

Review 7.  Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions.

Authors:  L C Rall; R Roubenoff
Journal:  Rheumatology (Oxford)       Date:  2004-08-03       Impact factor: 7.580

8.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

9.  Chronic inflammation modulates ghrelin levels in humans and rats.

Authors:  M Otero; R Nogueiras; F Lago; C Dieguez; J J Gomez-Reino; O Gualillo
Journal:  Rheumatology (Oxford)       Date:  2003-11-17       Impact factor: 7.580

Review 10.  The current biology of resistin.

Authors:  Claire M Steppan; Mitchell A Lazar
Journal:  J Intern Med       Date:  2004-04       Impact factor: 8.989

View more
  159 in total

1.  Nicotinamide Phosphoribosyltransferase in Human Diseases.

Authors:  Li Qin Zhang; Daniel P Heruth; Shui Qing Ye
Journal:  J Bioanal Biomed       Date:  2011-01-07

Review 2.  Rheumatoid cachexia and cardiovascular disease.

Authors:  Gregory D Summers; Giorgos S Metsios; Antonios Stavropoulos-Kalinoglou; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2010-07-20       Impact factor: 20.543

3.  Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis.

Authors:  Jennifer Kaplan; Marchele Nowell; Ranjit Chima; Basilia Zingarelli
Journal:  Innate Immun       Date:  2013-09-12       Impact factor: 2.680

Review 4.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

Review 5.  [Adipocytokines as driving forces in rheumatoid arthritis].

Authors:  E Neumann; A Knedla; F Meier; I H Tarner; C Büchler; A Schäffler; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2007-03       Impact factor: 1.372

6.  Visfatin levels in Behcet's disease.

Authors:  Hatice Sezen; Seydi Okumus; Yavuz Pehlivan; Ismail Dilli; Mehmet Tarakcioğlu; Ahmet Mesut Onat
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

7.  Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients.

Authors:  L Sieminska; D Niedziolka; A Pillich; B Kos-Kudla; B Marek; M Nowak; H Borgiel-Marek
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

Review 8.  Vascular effects of biologic agents in RA and spondyloarthropathies.

Authors:  Zoltán Szekanecz; György Kerekes; Pál Soltész
Journal:  Nat Rev Rheumatol       Date:  2009-11-10       Impact factor: 20.543

9.  Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?

Authors:  Shali Mazaki-Tovi; Roberto Romero; Sun Kwon Kim; Edi Vaisbuch; Juan Pedro Kusanovic; Offer Erez; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Chia-Ling Nhan-Chang; Nandor Gabor Than; Ricardo Gomez; Jyh Kae Nien; Samuel S Edwin; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08

Review 10.  Emerging role of leptin in rheumatoid arthritis.

Authors:  G Tian; J-N Liang; Z-Y Wang; D Zhou
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.